Increasing awareness and knowledge of Alpha-gal Syndrome in the United States

Summary

The CDC's National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) is seeking applications to increase public awareness and knowledge of Alpha-gal Syndrome (AGS) in the United States. AGS is a tick-bite-triggered allergy to red meat and other mammalian products. The opportunity is structured as a federal grant (RFA) rather than a traditional procurement contract. The full scope of work, deliverables, and award details are expected to be detailed in the full funding opportunity announcement.

How they evaluate

Risks & flags

• Opportunity is posted as a synopsis only — full funding opportunity announcement (FOA) details, eligibility requirements, and evaluation criteria are not yet available, limiting competitive assessment.
• Single disease focus (Alpha-gal Syndrome) may narrow the eligible applicant pool to a small number of subject-matter-expert organizations already working in this space.